Navelbine Safety Questions, Navelbine Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Navelbine side effects. Check out Health Surveys and Health Polls. If you have questions about Navelbine, you can post them to our Doctors or Ask Patient Community about Navelbine.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Navelbine
Navelbine Safety Reports
Total Navelbine reports: 89.Navelbine FDA safety alerts: No.
Reported deaths: 18 Reported hospitalizations: 30.
Take Navelbine Side Effects Survey or Share Your Navelbine Story.
Reported Navelbine Side Effects: neutropenia, anaemia, febrile neutropenia, leukopenia, vomiting, nausea, visual acuity reduced, infection, optic neuritis, dyspnoea, performance status decreased.
More About Navelbine.
Showing 1-50 of 89 Next >
Navelbine Side Effects Report #5421621-3Consumer or non-health professional from FRANCE reported NAVELBINE problem on Aug 24, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia. NAVELBINE dosage: 25 MG/M2 1 X WK IV. During the same period patient was treated with GEMZAR. Patient recovered.
Navelbine Side Effects Report #5421622-5
NAVELBINE problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, CHLORIDE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient recovered.
Navelbine Side Effects Report #5421623-7
Consumer or non-health professional from GREECE reported NAVELBINE problem on Aug 17, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, ONDANSETRON. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5421630-4
NAVELBINE problem was reported by a Consumer or non-health professional from ITALY on Aug 22, 2006. Male patient was diagnosed with prostate cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: granulocytopenia. NAVELBINE dosage: 10 MG/M2 QD IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5421631-6
Consumer or non-health professional from KOREA, REPUBLIC OF reported NAVELBINE problem on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, CHLORIDE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient recovered.
Navelbine Side Effects Report #5421632-8
NAVELBINE problem was reported by a Consumer or non-health professional from LEBANON on Aug 25, 2006. Female patient was diagnosed with breast cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenia. NAVELBINE dosage: 25 MG/M2 1 X WK IV. During the same period patient was treated with CAPECITABINE, DOCETAXEL. Patient recovered.
Navelbine Side Effects Report #5421633-X
Consumer or non-health professional from LEBANON reported NAVELBINE problem on Aug 25, 2006. Female patient was diagnosed with breast cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NAVELBINE dosage: 25 MG/M2 QD IV. During the same period patient was treated with CAPECITABINE, DOCETAXEL. Patient recovered.
Navelbine Side Effects Report #5421634-1
NAVELBINE problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, SALIINE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient recovered.
Navelbine Side Effects Report #5421649-3
Health Professional from KOREA, REPUBLIC OF reported NAVELBINE problem on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, CHLORIDE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient recovered.
Navelbine Side Effects Report #5421651-1
NAVELBINE problem was reported by a Health Professional from FRANCE on Feb 24, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, infection. NAVELBINE dosage: 12.5 MG/M2 IV. During the same period patient was treated with DOCETAXEL, METHYLPREDNISOLONE. Patient died.
Navelbine Side Effects Report #5421657-2
Physician from FRANCE reported NAVELBINE problem on Aug 22, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: infection. NAVELBINE dosage: 25 MG/M2 1 IN 1 WK IV. During the same period patient was treated with GEMZAR. Patient recovered.
Navelbine Side Effects Report #5421661-4
NAVELBINE problem was reported by a Health Professional from FRANCE on Aug 23, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: pulmonary toxicity. NAVELBINE dosage: 25 MG/M2 1 X WK IV. During the same period patient was treated with GEMZAR. Patient recovered.
Navelbine Side Effects Report #5421663-8
Health Professional from ITALY reported NAVELBINE problem on Aug 22, 2006. Male patient was diagnosed with prostate cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: asthenia. NAVELBINE dosage: 20 MG/M2 QD IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5421665-1
NAVELBINE problem was reported by a Health Professional from FRANCE on Aug 23, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, cardiotoxicity. NAVELBINE dosage: 25 MG/M2 1 X WK IV. During the same period patient was treated with GEMZAR. Patient recovered.
Navelbine Side Effects Report #5421853-4
Consumer or non-health professional from ITALY reported NAVELBINE problem on Aug 21, 2006. Male patient was diagnosed with prostate cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenia. NAVELBINE dosage: 20 MG/M2 UNK IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.
Navelbine Side Effects Report #5428568-7
NAVELBINE problem was reported by a Physician from UNITED STATES on June 07, 2006. Female patient was diagnosed with metastatic malignant melanoma and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenia. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428569-9
Physician from UNITED STATES reported NAVELBINE problem on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: lung disorder. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428570-5
NAVELBINE problem was reported by a Physician from UNITED STATES on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neutropenia. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428573-0
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: pain. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428574-2
NAVELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: renal disorder. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428590-0
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: hypertension. NAVELBINE dosage: 30 MG/M2 IV. Patient recovered.
Navelbine Side Effects Report #5428596-1
NAVELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: fatigue. NAVELBINE dosage: 30 MG/M2 UNK IV. Patient recovered.
Navelbine Side Effects Report #5428598-5
Physician from UNITED STATES reported NAVELBINE problem on May 23, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia. NAVELBINE dosage: 30 MG/M2 IV. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5428860-6
NAVELBINE problem was reported by a Consumer or non-health professional from FRANCE on May 05, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: renal failure. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with CISPLATIN. Patient died.
Navelbine Side Effects Report #5428861-8
Physician from GREECE reported NAVELBINE problem on Aug 17, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, ONDANSETRON. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5428862-X
NAVELBINE problem was reported by a Physician from ITALY on Aug 22, 2006. Female patient was diagnosed with prostate cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia. NAVELBINE dosage: 20 MG/M2 IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.
Navelbine Side Effects Report #5428863-1
Consumer or non-health professional from ITALY reported NAVELBINE problem on Aug 21, 2006. Female patient was diagnosed with prostate cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia. NAVELBINE dosage: 20 MG/M2 2 X WK IV. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, DEXAMETHASONE, METOCLOPRAMIDE. Patient recovered.
Navelbine Side Effects Report #5428864-3
NAVELBINE problem was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, pneumonia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, CHLORIDE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient died.
Navelbine Side Effects Report #5428866-7
Consumer or non-health professional from FRANCE reported NAVELBINE problem on Apr 24, 2006. Male patient was diagnosed with prostate cancer metastatic and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NAVELBINE dosage: 30 MG/M2 IV. During the same period patient was treated with HYDROCORTISONE. Patient recovered.
Navelbine Side Effects Report #5428867-9
NAVELBINE problem was reported by a Physician from SINGAPORE on Aug 22, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE. Patient recovered.
Navelbine Side Effects Report #5428868-0
Physician from GERMANY reported NAVELBINE problem on Aug 24, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: ileus paralytic. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE. Patient recovered.
Navelbine Side Effects Report #5470348-0
NAVELBINE problem was reported by a Consumer or non-health professional from ITALY on Aug 21, 2007. Male patient, 62 years of age, was diagnosed with lung squamous cell carcinoma stage iv and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. NAVELBINE dosage: 45 MG 1 X WK IV. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Navelbine Side Effects Report #5470349-2
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 03, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: renal failure acute. NAVELBINE dosage: 25 MG IV. During the same period patient was treated with GEMCITABINE. Patient recovered.
Navelbine Side Effects Report #5470350-9
NAVELBINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2007. Female patient, 68 years of age, was diagnosed with breast cancer recurrent and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac failure acute, hypotension, leukopenia, pain in extremity. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with MYSRON, LOXONIN, OXYCONTIN. Patient was hospitalized. Patient died on 08/23/2007.
Navelbine Side Effects Report #5470647-2
Consumer or non-health professional from GERMANY reported NAVELBINE problem on Aug 22, 2007. Female patient, 66 years of age, was diagnosed with breast cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. NAVELBINE dosage: 25 MG/M2 1 X WK IV. Patient recovered.
Navelbine Side Effects Report #5470648-4
NAVELBINE problem was reported by a Consumer or non-health professional from GERMANY on Aug 28, 2007. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, speech disorder, visual acuity reduced. NAVELBINE dosage: 45 MG QD IV. During the same period patient was treated with FORTECORTIN. Patient recovered.
Navelbine Side Effects Report #5472281-7
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure. NAVELBINE dosage: 25 MG/M2 IV. Patient died.
Navelbine Side Effects Report #5472282-9
NAVELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure. NAVELBINE dosage: 25 MG/M2 IV. Patient died.
Navelbine Side Effects Report #5472283-0
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: infection, performance status decreased. NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with DOCETAXEL. Patient died.
Showing 1-50 of 89 Next >